A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
12/2004
12/30/2004	US20040265321 A dimeric fusion protein having two identical polypeptide chains, each chain wtih an extracellular region of an activating Fc gamma R containing an Fc binding site, joined to a molecule that binds an Fc gamma Rn; dimeric fusion protein specifically binds an immune complex
12/30/2004	US20040265320 Administering a compound selected from 3-O-(3',3'-dimethylsuccinyl) betulinic acid, 3-O-(3',3'-dimethylsuccinyl) betulin, 3-O-(3',3'-dimethylglutaryl) betulin, 3-O-(3',3'-dimethylsuccinyl) dihydrobetulinic acid, 3-O-(3',3'-dimethylglutaryl) betulinic acid, (3',3'-dimethylglutaryl) dihydrobetulinic acid
12/30/2004	US20040265232 [18F]-furanosylpurine derivatives and uses thereof
12/29/2004	WO2004112730A2 Method and compositions for treating tumors
12/29/2004	WO2004112729A2 Dual function compounds and uses thereof
12/29/2004	WO2004112728A2 Methods and agents for treating axonal damage, inhibition of neurotransmitter release and pain transmission, and blocking calcium influx in neurons
12/29/2004	WO2004112727A2 Aav virions with decreased immunoreactivity and uses therefor
12/29/2004	WO2004112725A2 Methods for inhibiting or reversing tau filament fibrillization
12/29/2004	WO2004112724A2 Compositions for and methods for treating hiv
12/29/2004	WO2004112723A2 Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
12/29/2004	WO2004112722A2 Microbicidal, prophylactic and therapeutic effect of ctc-96 on papilloma viruses
12/29/2004	WO2004112721A2 Prevention or treatment of deficits that arise in connection with diseases of, or injuries to, the nervous system
12/29/2004	WO2004112720A2 Antiviral compositions and methods of using the same
12/29/2004	WO2004112719A2 Chemical compounds
12/29/2004	WO2004112718A2 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
12/29/2004	WO2004112717A2 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof
12/29/2004	WO2004112716A2 Prodrugs of heteroaryl compounds
12/29/2004	WO2004112715A2 Methods of making and using theaflavin,theaflavin-3-gallate, theaflavin-3’-gallate and theaflavin 3,3’ - digallate and mixtures thereof
12/29/2004	WO2004112714A2 Chemical compounds
12/29/2004	WO2004112713A2 Drug polymer complexes
12/29/2004	WO2004112712A2 Speculum assembly
12/29/2004	WO2004112711A2 Oral extended-release composition
12/29/2004	WO2004112710A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-ß
12/29/2004	WO2004112709A2 Inhibitors of cathepsin s
12/29/2004	WO2004112708A2 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
12/29/2004	WO2004112707A2 Method for purifying virus
12/29/2004	WO2004112706A2 Vaccines, immunotherapeutics and methods for using the same
12/29/2004	WO2004112705A2 Methods for treating sleep disorders
12/29/2004	WO2004112703A2 Interleukin-21 analogs
12/29/2004	WO2004112702A2 Low dose pharmaceutical powders for inhalation
12/29/2004	WO2004112701A2 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/29/2004	WO2004112700A2 Methods and compositions for modulating amyloid precursor protein translation
12/29/2004	WO2004112699A2 Mitotic kinesin inhibitors
12/29/2004	WO2004112698A2 Methods for obtaining anti-retroviral agents
12/29/2004	WO2004112697A2 Immune enhancing composition containing lactoferrin
12/29/2004	WO2004112696A2 Methods and compositions for delivery of catecholic butanes for treatment of diseases
12/29/2004	WO2004112695A2 Methods and compositions for delivery of catecholic butanes for treatment of obesity
12/29/2004	WO2004112694A2 Immunogenic reagents from west nile virus
12/29/2004	WO2004112693A2 Tissue protective cytokines with an extended therapeutic window
12/29/2004	WO2004112692A2 Therapeutic herbal compositions
12/29/2004	WO2004112691A2 Interferon gamma therapies for idiopathic pulmonary fibrosis
12/29/2004	WO2004112690A2 2-aminobenzoyl derivatives
12/29/2004	WO2004112688A2 7-alkyloxy-2h-1,4-benzoxacin-3(4h)-one derivatives and preparation method thereof
12/29/2004	WO2004112687A2 Antiviral acylguanidine compounds and methods
12/29/2004	WO2004096152A3 In situ gelling self-reactive materials for embolization
12/29/2004	WO2004096124A3 Compositions and methods for the diagnosis and treatment of tumor
12/29/2004	WO2004093790A3 Yeast ectopically expressing abnormally processed proteins and uses therefor
12/29/2004	WO2004092146A3 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes
12/29/2004	WO2004091512A3 Abuse-resistant oral dosage forms and method of use thereof
12/29/2004	WO2004087067A3 Treatment of aspergillus infections with thymosin alpha 1
12/29/2004	WO2004084819A3 Poly(acryloyl-hydroxyethyl starch)-plga composite microspheres
12/29/2004	WO2004082640A3 Human serum albumin conjugates with therapeutic compounds
12/29/2004	WO2004082630A3 High potency dopaminergic treatment of neurological impairment associated with brain injury
12/29/2004	WO2004082618A3 Synthesis of 5-azacytidine
12/29/2004	WO2004078119A3 Substituted thiophenes with antibacterial activity
12/29/2004	WO2004076412A3 Aminoheteroaryl compounds as protein kinase inhibitors
12/29/2004	WO2004075853A3 Halogenated triptolide derivatives as immunomodulators and anticancer agents
12/29/2004	WO2004075815A3 Diarylcycloalkyl derivatives, method for their production and their use as medicaments
12/29/2004	WO2004071469A3 Methods of administering a dermatological agent to a subject
12/29/2004	WO2004066951A3 Quinoline derivatives as nk-2 and nk-3 receptor antagonists
12/29/2004	WO2004064733A3 The use of c-raf inhibitors for the treatment of neurodegenerative diseases
12/29/2004	WO2004064727A3 Method of cancer treatment using hdac inhibitors
12/29/2004	WO2004058329A3 Ester combination local anesthetic
12/29/2004	WO2004046068A3 Non-steroidal farnesoid x receptor modulators and methods for the use thereof
12/29/2004	WO2004026232A3 Vaginal health products
12/29/2004	WO2004015072A3 Mrbs as modifiers of the rb pathway and methods of use
12/29/2004	WO2003092542A8 Injectable chondrocyte implant
12/29/2004	WO2003045392A8 Use of n-(indolcarbonyl-)piperazine derivatives
12/29/2004	EP1491556A1 Humanized immunoglobulins and their production and use
12/29/2004	EP1491236A1 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
12/29/2004	EP1490361A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
12/29/2004	EP1490049A1 Citalopram for the treatment of elevated blood pressure
12/29/2004	EP0869958B1 Novel indole-2,3-dione-3-oxime derivatives
12/29/2004	EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004	CN1558754A Pharmaceutical dosage form with multiple coatings
12/29/2004	CN1182123C Substituted bicyclic derivatives useful as anticancer agents
12/29/2004	CN1181886C Application of TNF-derived peptides in the treatment of oedema
12/29/2004	CN1181826C Lipid-based immune regulator composition
12/29/2004	CN1181814C Fast oral dissolving films containing an ion exchange resin as a taste masking agent
12/29/2004	CA2673334A1 Oral extended-release composition
12/29/2004	CA2531671A1 Immune enhancing composition containing lactoferrin
12/29/2004	CA2529955A1 Microbicidal, prophylactic and therapeutic effect of ctc-96 on papilloma viruses
12/29/2004	CA2529949A1 Antiviral compounds and methods
12/29/2004	CA2529854A1 Methods for inhibiting or reversing tau filament fibrillization
12/29/2004	CA2529852A1 Compositions for and methods for treating hiv
12/29/2004	CA2529847A1 Antiviral compositions and methods of using the same
12/29/2004	CA2529761A1 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
12/29/2004	CA2529528A1 Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
12/29/2004	CA2529520A1 Interleukin-21 analogs
12/29/2004	CA2529503A1 Drug polymer complexes
12/29/2004	CA2529500A1 Prodrugs of heteroaryl compounds
12/29/2004	CA2529053A1 Method for purifying virus
12/29/2004	CA2529051A1 Vaccines, immunotherapeutics and methods for using the same
12/29/2004	CA2528538A1 Dual function compounds and uses thereof
12/29/2004	CA2527806A1 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/29/2004	CA2527533A1 Mitotic kinesin inhibitors
12/29/2004	CA2526640A1 Immunogenic reagents from west nile virus
12/29/2004	CA2526096A1 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
12/28/2004	US6835751 Bicyclic amino acids as pharmaceutical agents
12/28/2004	US6835388 Mixing a compound which acts as a local anesthetic with physiological salt; placing formulation in a catheter; administering formulation into uterine cavity of woman with a catheter; pertubating the formulation into peritoneal cavity

1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 295